AAMI vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 14, 2026

AAMI

63.2
AI Score
VS
AAMI Wins

CNS

57.6
AI Score

Investment Advisor Scores

AAMI

63score
Recommendation
BUY

CNS

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAMI CNS Winner
Revenue 167.00M 94.41M AAMI
Net Income 24.30M 29.96M CNS
Net Margin 14.6% 31.7% CNS
Operating Income 41.90M 36.29M AAMI
ROA 3.4% 6.7% CNS
Total Assets 715.40M 450.12M AAMI

Relative Price Performance (Last 90 Days)

AAMI 1M: +22.4% · 3M: +36.6% CNS 1M: +6.8% · 3M: +21.2%

Current Technical Phase

AAMI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.6% over 20 days), RSI 68

RSI (14): 68.4 · Price: $89.48

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 64

RSI (14): 64.5 · Price: $83.95

Fundamentals Snapshot

Metric AAMI CNS
Market Cap
Forward P/E 13.7 21.2
Trailing P/E 34.4 25.1
Revenue (TTM)
Revenue Growth 0.4% 0.1%
Gross Margin 0.4% 0.5%
Operating Margin 0.3% 0.3%
EPS 2.44 3.25
Dividend Yield 0.00% 0.03%

Frequently Asked Questions

Based on our detailed analysis, AAMI is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.